The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis-Reference-Cited by-同舟云学术

The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis

Published:2014-09-17 Issue:18 Volume:13 Page:2889-2900
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Jirawatnotai Siwanon,Sharma Samanta,Michowski Wojciech,Suktitipat Bhoom,Geng Yan,Quackenbush John,Elias Joshua E,Gygi Steven P,Wang Yaoyu E,Sicinski Piotr

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/15384101.2014.946850

Reference49 articles.

1. Living with or without cyclins and cyclin-dependent kinases

2. Cyclin D1 protein expression and function in human breast cancer

3. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer;Translational Lung Cancer Research;2024-05

2. Type I IFN expression is inhibited during cell division by CDK4/6;2023-04-16

3. Mitochondrial–nuclear communication by FKBP51 shuttling;Journal of Cellular Biochemistry;2023-02-23

4. Structural and biochemical insights into FKBP51 as a Hsp90 co‐chaperone;Journal of Cellular Biochemistry;2023-02-15

5. Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape;Oncology Research;2023